USE OF THE CHELATING AGENT CLIOQUINOL FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE

摘要

A new pharmaceutical composition is disclosed that comprises clioquinol, vitamin B12, and, optionally, pharmaceutical acceptable carriers and/or excipients. The use of the pharmaceutical composition removes or alleviates the side effects of clioquinol.